To investigate diagnostic aspects of invasive aspergillosis (IA) in allogeneic BMT recipients, the charts of 22 consecutive patients with IA transplanted in 1989-1995 were reviewed. IA was diagnosed 69-466 days (median 131 days) post BMT. In 16 patients (73%), a definite or probable diagnosis of IA was made during life. Respiratory symptoms were the presenting feature in half of the patients followed by neurological symptoms (27%). Chest X-ray revealed single or multiple nodular lesions in 10 patients; cavitation was observed in five patients. Tissue biopsy was the most common method of diagnosis (nine patients: lungs 6, liver 1, subcutaneous tissue 1, brain 1). Five IA cases were detected by nine guided fine needle lung biopsies in eight patients and without complications. Bronchoalveolar lavage was performed in 14 patients with findings suggestive of invasive pulmonary aspergillosis in eight cases. Lungs were the most common organ affected (90%) followed by central nervous system (41%). The diagnosis of IA is still difficult, and a large number of patients have advanced infection at diagnosis. Methods for early diagnosis are needed. Patients with a clinical suspicion of IA should be treated vigorously with antifungal agents during the diagnostic work-up. Bone Marrow Transplantation (2000) 25, 867-871. Keywords: Aspergillus infection; allogeneic BMT; diagnosis; radiology; biopsy; bronchoalveolar lavage Invasive aspergillosis (IA) is an important clinical problem in allogeneic BMT recipients. In previous studies, the incidence of IA has ranged from 4 to 10% 1-5 and may be increasing. 6 Aspergillus infections have been considered difficult to diagnose.
Invasive aspergillosis (IA) is an important clinical problem in allogeneic BMT recipients. In previous studies, the incidence of IA has ranged from 4 to 10% [1] [2] [3] [4] [5] and may be increasing. 6 Aspergillus infections have been considered difficult to diagnose. [7] [8] [9] They often present with non-specific symptoms and signs. In the allogeneic setting other opportunistic infections may make the diagnosis of IA even more difficult. Due to frequent colonization of the upper respiratory tract with Aspergillus sp, tissue biopsy is needed for definitive diagnosis.
Correspondence: Dr E Jantunen, Department of Medicine, Kuopio University Hospital, PO Box 1777, SF-70211 Kuopio, Finland Received 9 August 1999; accepted 24 November 1999 Knowledge of the spectrum of clinical presentation of IA is essential both for raising clinical suspicion and for guiding diagnostic attempts. Furthermore, information on the yield of different diagnostic methods is needed in choosing rational diagnostic strategies. We have therefore analyzed our experience on the diagnostic aspects of IA in a recent cohort of allogeneic BMT recipients.
Patients and methods
From January 1989 to December 1995, 205 adult patients (у16 years) received their first allogeneic BMT at the Department of Medicine, Helsinki University Central Hospital. One hundred and seventy-three patients had an HLAmatched sibling donor, in one case there was a one-antigen mismatch, and 31 patients had an HLA-matched unrelated donor. All patient charts were screened for baseline data, post-transplant course, and occurrence of Aspergillus infection. Autopsy data were also reviewed when available.
All patients were cared for in single rooms with HEPA filters from the beginning of the conditioning therapy until engraftment. No systemic antifungal prophylaxis was used. Systemic antifungal agents, primarily amphotericin B (0.5 mg/kg/day), were given empirically for neutropenic fever unresponsive to broad-spectrum antibiotics given for at least 4 days.
In cases of suspected lung problems, conventional chest X-ray was usually followed by computed tomography (CT). In patients with pulmonary infiltrates, fiberoptic bronchoscopy with bronchoalveolar lavage (BAL) and brushing was carried out, especially in patients with diffuse pulmonary infiltrates. In patients with focal pulmonary lesions radiologically guided fine needle biopsy (FNB) was considered the first-line diagnostic tool.
Microbiological methods
Standard microbiological methods for direct microscopy, culture and identification of fungi were used. 10, 11 Neither antigen tests [12] [13] [14] [15] [16] nor culture or microscopy of sputum 17, 18 were used for the diagnostics of Aspergillus infections during the study period.
Diagnostic criteria for invasive aspergillosis
Definite IA was defined as the demonstration of filamentous fungi with microscopy from tissue samples taken during life or at autopsy with or without a positive culture for Aspergillus sp. Probable invasive pulmonary aspergillosis (IPA) was defined as the demonstration of filamentous fungi compatible with the morphology of Aspergillus and/or a positive culture for Aspergillus sp from specimen taken at BAL in patients with radiological findings suggestive of pulmonary fungal infection.
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Data collection
In patients with definite IA or probable IPA, data of clinical history, laboratory, and radiological findings before the diagnosis of IA were recorded from the patient charts. Diagnostic attempts (radiological studies, BAL studies, biopsies) performed within 30 days prior to the diagnosis of IA were also included. The patient was considered febrile if the axillary temperature was Ͼ38°C at least once within a week preceding the diagnosis of IA. GVHD was classified according to published criteria 22, 23 . Autopsy data were also recorded when available.
Results
Of the 205 consecutive patients transplanted in 1989-1995, 22 (11%) were diagnosed as having IA. A definitive diagnosis of IA was made in 18 patients, whereas four patients had probable IPA. The median time to diagnosis was 131 days post-transplant (range 69-466 days). There were 10 females and 12 males with a median age of 42 years (range 17-47 years). Underlying hematological diagnoses included AML (n = 5), MDS (n = 5), ALL (n = 4), CML (n = 3) and others (n = 5). The marrow donor was an HLA-identical sibling in 16 cases; six patients had an unrelated donor.
Post-transplant course before the diagnosis of IA
All patients engrafted (ANC Ͼ0.5 × 10 9 /l) at a median of 17 days (range 13-32 days) post BMT. However, 13 out of 22 patients (59%) developed late neutropenia (ANC Ͻ1.5 × 10 9 /l) for a median of 5 days (range 2-28 days). A great majority of the patients had GVHD (Table 1) ; only Table 1 Incidence and treatment of GVHD in 22 patients with invasive aspergillosis prior to the diagnosis of fungal infection three patients with IA had no aGVHD and/or extensive cGVHD. Thirteen patients (59%) were on CsA and all were taking methylprednisolone (0.25-15 mg/kg/day, median 0.6 mg/kg/day) at the time of the diagnosis of IA. Fourteen patients (64%) received amphotericin B (AmB) on an empirical basis after BMT. The median cumulative dose of AmB before the diagnosis of IA was 5 mg/kg (range 1-20 mg/kg). One patient with a history of IPA before BMT received liposomal AmB after BMT.
Clinical and laboratory features at diagnosis of IA
Respiratory symptoms were the most common presenting clinical features of IA followed by neurological symptoms ( Table 2) . No patient presented with hemoptysis. Only seven patients (32%) were febrile (Ͼ38°C) within a week preceding the diagnosis.
The median ANC count was 1.2 × 10 9 /l (range 0.1-9.2 × 10 9 /l). In seven patients (32%), the ANC was Ͻ0.5 × 10 9 /l. The serum C-reactive protein (CRP) ranged from 5 mg/l to 384 mg/l (median 58 mg/l, reference value Ͻ10 mg/l). In five patients (23%), CRP was Ͻ20 mg/l at diagnosis. On the other hand, all patients diagnosed to have IA for the first time at autopsy had high CRP values just prior to death (147-384 mg/l, median 320 mg/l).
Radiological findings in the lungs
Chest X-ray had been taken within 30 days prior to the diagnosis in 21 patients; in one patient radiological assessment was based only on CT. Out of 17 patients with abnormal findings (Table 3) , single or multiple nodular pulmonary lesions were observed initially in 10 patients (47% of all). Single or multiple cavitations were observed in five patients (23%).
Thoracic computed tomography (CT) was performed at least once on 16/22 patients within 30 days prior to the diagnosis of IA. In 12 patients (75%) single or multiple pulmonary focal lesions corresponding to the findings in the chest X-ray were also observed on CT (Table 3) . One patient with a normal chest X-ray had multiple small nodular lesions on the subsequent CT, and in another patient the findings on CT were more widespread than on chest X-ray. 
Diagnosis of Aspergillus infections in BMT recipients
E Jantunen et al 869
Diagnosis of Aspergillus infections
Definite or probable IA was diagnosed during life in 16/22 patients (73%) (definite IA in nine patients, probable IPA in seven patients with a subsequent confirmation at autopsy in three). Altogether, 13 tissue biopsies were performed on 11 patients within 30 days prior to the diagnosis of IA. The median time from an abnormal radiological finding to tissue biopsy was 3 days (range 1-22 days). Nine radiologically guided fine needle lung biopsies (FNB) were performed on eight patients without complications. The findings were suggestive of IA in five patients. In one of these patients only the second attempt yielded a positive result. In two patients IA was found at autopsy although an FNB with negative result had been performed 2 and 23 days prior to death, respectively. In three other patients biopsy of a subcutaneous abscess, brain, and liver yielded the diagnosis of IA. In addition, a definitive diagnosis of IA was established in one patient on open lung biopsy after a negative finding from a prior FNB. Bronchoalveolar lavage (BAL) was performed at least once on 14 patients Ͻ30 days preceding the diagnosis of IA. The median time from the first abnormal radiological finding to BAL was 1 day (range 0-21 days). The findings on microscopy and culture of bronchial brush and lavage samples were suggestive of IPA in eight patients (57%). Aspergillus sp was isolated in six patients (A. fumigatus in all), and microscopic identification of filamentous fungi was accomplished in five patients.
Of the eight patients with findings suggestive of IA in BAL, the final diagnosis was probable IPA in four. In another four patients, a diagnosis of definite IA was subsequently made by either FNB (one patient) or autopsy (three patients). However, in six patients (eight BAL procedures) with definitive IA (biopsy 3, autopsy 3), BAL was either negative or yielded unrelated findings (Pneumocystis carinii 2, cytomegalovirus 1, Xanthomonas maltophilia 1).
The mycological species identification was A. fumigatus in all 16 patients with fungal isolation. In addition, A. flavus Bone Marrow Transplantation was isolated in one patient from BAL fluid and A. niger in another patient from the maxillary sinus. One patient had a concomitant invasive Candida infection. In six patients, no fungal isolation was made, and the diagnosis of Aspergillus infection was based only on the morphological identification of filamentous fungal elements.
Autopsy was performed in 15 patients. Six patients were diagnosed as having IA on the basis of the autopsy findings; five of these patients were already receiving amphotericin B. In three patients with a diagnosis of probable IPA, a definite diagnosis was made at autopsy.
Ten patients were autopsied at the Department of Pathology, University of Helsinki with an identical autopsy protocol. Pulmonary involvement was found in nine patients (90%) and CNS involvement in seven patients (70%) followed by the involvement of heart (four patients), thyroid gland (three patients), gut (two patients) and liver, kidneys and pancreas (one patient each).
On the basis of the available evidence, IPA was found in nine patients (41%), and 13 patients were found to have disseminated aspergillosis (involvement of at least two noncontinuous organs). The most common organs affected by aspergillosis were lungs (20 patients, 90%) followed by CNS (definite eight patients, probable one patient, 41%).
Discussion
In the present retrospective study we analyzed the diagnostic aspects of invasive aspergillosis in 22 allogeneic BMT recipients. Late onset, non-specific symptoms, often afebrile onset and frequent disseminated disease type with CNS involvement highlight diagnostic problems in these patients who often have concomitant GVHD and mixed infections. The above aspects seem to differ from the experiences gained in, for example, hematological patients with Aspergillus infections after conventional chemotherapy. 8, 24 Few attempts have been made to describe the clinical features of IA in BMT recipients. In our analysis, more than half of the patients were afebrile at diagnosis, thus making clinical suspicion of a potentially fatal infection less likely. An explanation for this might be the use of corticosteroids in all patients at the time of the diagnosis of IA. Only half of the patients reported respiratory symptoms, though this is difficult to ascertain retrospectively. A significant proportion of the patients presented with neurological symptoms and signs, which is in accordance with the findings reported by Saugier-Veber and co-workers. 3 The serum level of CRP, a valuable indicator of systemic inflammatory response, has not been analyzed in previous studies of IA after BMT. We observed unexpectedly low levels for CRP in many patients diagnosed as having IA during life. This suggests that in these patients the degree of tissue invasion and necrosis caused by Aspergillus sp might be low. On the other hand, very high CRP levels were found in the majority of the patients with an autopsy diagnosis of disseminated IA. Thus, CRP seems to have only limited diagnostic value in this context.
Radiological findings were suggestive of IPA in about half of the patients just prior to diagnosis. However, a significant proportion of patients presented with diffuse pul-monary infiltrates, which could have been caused by many other pathogenic organisms besides Aspergillus sp. In some patients, concomitant bacterial or viral infection was, in fact, diagnosed simultaneously with IA. It has been shown that thoracic CT is useful in some neutropenic patients with normal chest X-ray 25, 26 or after BMT 20, 27 in the early detection and management of IPA. In this study, thoracic CT performed shortly after chest X-ray yielded, in most cases, comparable findings, but in some patients CT disclosed pulmonary pathology more clearly than did chest X-ray. In this retrospective analysis, the contribution of CT to the early diagnosis of pulmonary aspergillosis was perhaps less impressive when compared to a prospective study, where serial CT studies using high-resolution techniques have been used. 26 An additional advantage of thoracic CT in this context is that CT shows the exact localization of lesions and is helpful in choosing the best method (BAL or biopsy) and site for diagnostic sampling.
Fine needle biopsy of the lungs has not been widely used in BMT patients. In the present series, several radiologically guided FNBs were performed with a rather high diagnostic yield and without complications. We had, however, four false negative findings on single FNBs, suggesting that therapeutic decisions cannot be made solely on this basis. Open lung biopsy, especially via thoracoscopy, is an alternative diagnostic method if technically feasible and may offer more representative tissue samples for culture and microscopy.
Bronchoalveolar lavage has been widely used in the diagnosis of lung problems in immunocompromised patients. In the present material, BAL yielded the diagnosis of probable IPA in 57% of patients. This figure is the same as in a recent multi-institutional prospective survey of hematological patients conducted by EORTC. 8 In BMT recipients with pulmonary pathology, a finding of Aspergillus from a BAL specimen either by culture or microscopy is suggestive of IPA 2, 3 and an indication for therapy. In our study, BAL was non-diagnostic in some patients just before the diagnosis of IPA. On the other hand, BAL may also offer useful microbiological information regarding other pulmonary pathogens, [28] [29] [30] which was also observed in this study.
The diagnostic approach used in this patient cohort resulted in a relatively high percentage of diagnoses of IA (73%) made during life. In addition, five out of six patients diagnosed as having IA for the first time at autopsy received AmB based on clinical suspicion of a fungal infection. In a report by Saugier-Veber et al, 3 the diagnosis of IA was made during life in 61% of patients. McWhinney and coworkers 2 reported an even higher percentage of diagnosis during life (80%).
Diagnosis of invasive Aspergillus infection in allogeneic BMT recipients still seems to be a difficult task, and many patients have an advanced infection at the time of diagnosis. Early diagnosis of IA is essential, as the infection is difficult to treat and the costs of therapy are high. Since the clinical and radiological features of IA are often nonspecific, early empirical therapy with amphotericin B is suggested along with appropriate diagnostic studies. Newer methods for early diagnosis including Aspergillus antigen studies or polymerase chain reaction techniques may allow earlier diagnosis and improved management of IA in allogeneic BMT recipients.
